Navigation Links
Chemizon Announces Research Collaboration Expansion With Takeda
Date:10/1/2007

LONGMONT, Colo., Oct. 1 /PRNewswire/ -- Chemizon (010170, KOSDAQ) announced today that it has reached an agreement with Takeda Pharmaceutical Company Limited, to expand its current research collaboration focused on utilizing Chemizon's discovery platform.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070606/LAW174LOGO)

As part of the agreement, Chemizon will commit a majority of its current Korean site to the Takeda partnership. In addition, Chemizon will expand its Korean operations to accommodate future growth.

"Takeda is a premier global pharmaceutical company and we are delighted that they have chosen Chemizon as a preferred partner," said Dr. Tony Piscopio, Chairman and CEO of Chemizon. "Our highly motivated scientific team's commitment to excellence remains the foundation for Chemizon's rapid growth. As we add biology capabilities to our integrated discovery platform, our partners will be able to leverage a number of additional options that will become available in the near future."

About Chemizon Inc.:

Chemizon, a division of Optomagic Co. Ltd., is a global provider of drug discovery and development capabilities to the pharmaceutical industry. Anchored by an experienced management team, Chemizon combines its vertically integrated discovery platform with a flexible, collaborative business model to develop best-in-class clinical candidates. Our expertise spans a broad range of therapeutic areas and target classes. In addition to providing an integrated discovery solution, we assist our collaborators with stand alone services including: lead optimization, library design and synthesis, custom synthesis, radiolabeling, ADME profiling, analytical method development and process chemistry.

About Takeda Pharmaceutical Company Limited

Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals.
'/>"/>

SOURCE Chemizon Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...nd what 2-D images represent, researchers say , ...ys can recognize photographs of other monkeys they...es in faces and figure out if they,ve seen them be...s that capuchin monkeys can decipher the two-dimen...ors noted. , The findings, reported by research...
(Date:12/4/2009)...recommend its use, experts say , , , FR...glaucoma patients and others can benefit from medi...t can help multiple sclerosis (MS) patients find r... of the debilitating autoimmune disease. , "The...rs to be comprehensive, and should be given consid...
(Date:12/4/2009)...e/ -- Yogen Fruz , the world,s leading frozen yog...s holiday themed "NUmixes" -- Yog-Nog and Mint ...xes will be unveiled at Yogen Fruz stores across N... Mint Chocolate Chip flavors will offer customers ...s holiday season. ,, "We are always looking f...
(Date:12/4/2009)...c. 4 AES Annual Meeting,...announced today that Vagus Nerve Stimulation (VNS...cal device for the treatment of refractory epileps...erican Epilepsy Society,s (AES) Annual Meeting , t...enter in Boston, Massachusetts. ,, Robert Ell...
(Date:12/4/2009)...ing developer of novel and effective computational...h MolPort, an innovator in rare chemical trading.,...g platform and builds database of commercially ava... its updates to computational chemists at InhibOx ...ng procedures. Once they identify suitable lead ca...
Breaking Medicine News(10 mins):Health News:Review Finds Marijuana May Help MS Patients 2Health News:Review Finds Marijuana May Help MS Patients 3Health News:Yogen Fruz Introduces New Holiday Flavors: Yog-Nog and Mint Chocolate Chip 2Health News:NYU Langone Medical Center Study Shows VNS Therapy is a Safe and Effective Treatment for Refractory Epilepsy 2Health News:NYU Langone Medical Center Study Shows VNS Therapy is a Safe and Effective Treatment for Refractory Epilepsy 3Health News:InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 2Health News:InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 3
... suggest finding could lead to ways to decode the ...Y, March 5 (HealthDay News) -- Using brain scans a...ound a way to "read" visual activity in the brain....se of brain activity-image links is then created, ...
...Y, Pa., March 5 Secretary of,Health Dr. Calvin B....ty,Area family Center in Ellwood City to discuss G... to health insurance to hundreds of thousands of,u...nage chronic diseases, such as diabetes and asthma...
...ampions Assert, "We are especially opposed to thos...NGTON, March 5 The American Health Care,Associati...rs of the U.S.,House of Representatives who have s...nd Ranking Member Paul,Ryan (R-WI), asking them to...
...a long-standing biological mystery, UCLA stem cell..., the cells that later differentiate into all the ...red in the placenta. , The discovery may allow r...ating diseases like leukemia and aplastic anemia, ...
...Va.Researchers involved in a large, multi-institut...T) imaging with the radiotracer fluorodeoxyglucose...mentia with very high rates of success, raising ho... differentiate various types of dementia, said Lis...
...March 5 Secretary of Health Dr.,Calvin B. Johnson...ity,Health Net Dental Clinic to discuss Governor E...h insurance to hundreds of thousands of uninsured,...nic diseases such as diabetes and asthma, and to,r...
Other Medicine News:Health News:Brain Scans Let Computer 'Read' Visual Activity 2Health News:Brain Scans Let Computer 'Read' Visual Activity 3Health News:Health Secretary Visits Lawrence County to Call for Health Insurance for All Pennsylvanians 2Health News:Budget Committee Urged to Strongly Oppose Administration's Proposed $24 Billion, Five-Year Cuts to Medicare 2Health News:Budget Committee Urged to Strongly Oppose Administration's Proposed $24 Billion, Five-Year Cuts to Medicare 3Health News:UCLA researchers find blood stem cells originate and are nurtured in the placenta 2Health News:UCLA researchers find blood stem cells originate and are nurtured in the placenta 3Health News:PET's targeted imaging may lead to earlier diagnosis of dementia and Alzheimer's disease 2Health News:PET's targeted imaging may lead to earlier diagnosis of dementia and Alzheimer's disease 3Health News:Pennsylvania Health Secretary Urges Prompt Action on Health Insurance for All Pennsylvanians 2
(Date:12/3/2009)..., , DOYLESTOWN, Pa., Dec. 3 /PRNews... The Quigley Corporation, (Nasdaq: QGLY ) www.qu...completed its evaluation of its opportunities to d...s and has concluded that it is in its best interes...ketplace, which may include but are not limited to...
(Date:12/3/2009)..., , FORT WORTH, Texas, Dec. 3 /P...ogies, Inc. (OTC Bulletin Board: WNDM), a rapidly ...nounced today an agreement with the Health Industr...non-exclusive independent sales and marketing repr...x® product within the U.S. ,, HIRA will...
(Date:12/3/2009)..., , ST. PAUL, Minn., Dec. 3 /PRNewswire/ -...mpany, announced that it has completed a second ro...on. The funds will be used to complete a clinical ...ietary implantable technology designed to treat ob... the financing include Domain Associates, New Ente...
Breaking Medicine Technology:Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Apnex Medical, Inc. Raises Additional $14 Million 2Apnex Medical, Inc. Raises Additional $14 Million 3Lumbar Spinal Stenosis Surgery at the Olympia Medical Center 48340 1Lumbar Spinal Stenosis Surgery at the Olympia Medical Center 48340 2Early Bedtime May Help Stave Off Teen Depression 48337 1Early Bedtime May Help Stave Off Teen Depression 48337 2Early Bedtime May Help Stave Off Teen Depression 48337 3Herley Receives a 241 2 Million Contract Award for Complex Integrated Microwave Assemblies for U S Electronic Attack Aircraft 48334 1Herley Receives a 241 2 Million Contract Award for Complex Integrated Microwave Assemblies for U S Electronic Attack Aircraft 48334 2
... (the,"Company") (OTC Pink Sheets: XNOM; FWB: XE7)...stic technologies, announced today issuance of its...sequences in urine," RE39,920,that covers use of i...in,the area of infectious disease diagnostics and ...Tr-RNA) are fragments of DNA and,RNA from cells dy...
...rs from Lilly Foundation Could ,Fill a ...K, Nov. 14 The Juvenile Diabetes,Research Foundat... they are,joining together to create a $3 million ... into drugs and therapies to cure diabetes and its...ors that can measure the,progress of disease and t...
Other Medicine Technology:Xenomics Announces Issuance of a US Patent That Covers Use of Transrenal Nucleic Acid Technology for Infectious Disease Diagnostics and Monitoring 2Xenomics Announces Issuance of a US Patent That Covers Use of Transrenal Nucleic Acid Technology for Infectious Disease Diagnostics and Monitoring 3JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers 2JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers 3JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers 4
...rument program offers state-of-the-art quality in ...taining strength and durability. Low profile cutti...paces. Series I instruments are available in just ...ired for large and small joint arthroscopic proced...
...rument program offers state-of-the-art quality in ...taining strength and durability. Low profile cutti...paces. Series I instruments are available in just ...ired for large and small joint arthroscopic proced...
...rument program offers state-of-the-art quality in ...taining strength and durability. Low profile cutti...paces. Series I instruments are available in just ...ired for large and small joint arthroscopic proced...
...rument program offers state-of-the-art quality in ...taining strength and durability. Low profile cutti...paces. Series I instruments are available in just ...ired for large and small joint arthroscopic proced...
Medicine Products: